Ana Aldea‐Perona

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury

Inmaculada Medina‐Cáliz, Mercedes Robles‐Díaz, B. García‐Muñoz et al. · Journal of Hepatology · 2016 · 146 citations · Full text

Substance Abuse, Hepatology, Addiction +13

Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

Inmaculada Medina‐Cáliz, Miren García‐Cortés, A. González-Jiménez et al. · Clinical Gastroenterology and Hepatology · 2018 · 106 citations · Full text

Nutrition, Hepatology, Herbal Medicine +8

Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase®

Ana Aldea‐Perona, Mar García-Sáiz, Emílio J. Sanz · Drug Safety · 2015 · 93 citations

Disproportionality Analysis, Psychiatry, Psychiatric Disorders +11

Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute <scp>ST</scp>‐elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial

Alberto Domínguez‐Rodríguez, Pedro Abreu-González, José M. de la Torre-Hernández et al. · Journal of Pineal Research · 2016 · 82 citations

Adult Cardiac Surgery, Coronary Artery Disease, Acute Myocardial Infarction +16

Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial)

Alberto Domínguez‐Rodríguez, Pedro Abreu-González, José M. de la Torre-Hernández et al. · The American Journal of Cardiology · 2017 · 78 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Angioplasty Trial +8